Literature DB >> 30244644

BMS - Consensus statement.

Joan Pitkin1.   

Abstract

Urogenital atrophy is more common than it would first appear and women do not always seek advice and guidance. Confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations but new treatment modalities have emerged that extend the range of options beyond lubricants, moisturisers and vaginal estrogen preparations.

Entities:  

Keywords:  dryness dyspareunia; genito-urinary syndrome of menopause (GSM); non-hormonal ubricants and moisturisers; pruritus; sexual dysfunction; urogenital atrophy; vaginal soreness; vulvovaginal atrophy

Mesh:

Substances:

Year:  2018        PMID: 30244644     DOI: 10.1177/2053369118795349

Source DB:  PubMed          Journal:  Post Reprod Health        ISSN: 2053-3691


  2 in total

Review 1.  Using menopausal hormone therapy after a cancer diagnosis in Ireland.

Authors:  Fionán Donohoe; Yvonne O'Meara; Aidin Roberts; Louise Comerford; Catherine M Kelly; Janice M Walshe; Deirdre Lundy; Martha Hickey; Donal J Brennan
Journal:  Ir J Med Sci       Date:  2022-02-09       Impact factor: 1.568

Review 2.  Modern management of genitourinary syndrome of menopause.

Authors:  Ana Sofia Da Silva; Georgina Baines; George Araklitis; Dudley Robinson; Linda Cardozo
Journal:  Fac Rev       Date:  2021-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.